Connection

JOSEPH JANKOVIC to Vesicular Monoamine Transport Proteins

This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Vesicular Monoamine Transport Proteins.
  1. Real-World Experience With VMAT2 Inhibitors. Clin Neuropharmacol. 2019 Mar/Apr; 42(2):37-41.
    View in: PubMed
    Score: 0.630
  2. Deutetrabenazine for the treatment of Huntington's chorea. Expert Rev Neurother. 2018 08; 18(8):625-631.
    View in: PubMed
    Score: 0.604
  3. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs. 2018 04; 78(5):525-541.
    View in: PubMed
    Score: 0.591
  4. Real-world experience with VMAT2 inhibitors in Tourette syndrome. J Neurol. 2023 Sep; 270(9):4518-4522.
    View in: PubMed
    Score: 0.212
  5. Treatment of Tardive Dyskinesia. Neurol Clin. 2020 05; 38(2):379-396.
    View in: PubMed
    Score: 0.169
  6. Treatment options for chorea. Expert Rev Neurother. 2018 Jan; 18(1):51-63.
    View in: PubMed
    Score: 0.144
  7. Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease. CNS Neurol Disord Drug Targets. 2012 Sep; 11(6):768-73.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.